References
-
1
Barrons R W.
Drug induced neuromuscular blockade and myasthenia gravis.
Pharmacology.
1997;
17
1200-1203
-
2
De Giorgio C M, Rabinowicz A L, Olivas R D.
Carbamazepine-induced antinuclear antibodies and systemic lupus erythematosus-like syndrome.
Epilepsia.
1991;
32
128-129
-
3
Jain K K.
Systemic lupus erythematosus (SLE)-like syndromes associated with carbamazepine therapy.
Drug Saf.
1991;
6
350-360
-
4
Kanno T, Miyata M, Kazuta Y, Sato Y, Nishimaki T, Kasukawa R.
Carbamazepine-induced systemic lupus erythematosus-like disease.
Intern Med.
1992;
31
1303-1305
-
5
Keesey J C.
Does myasthenia gravis affect the brain?.
J Neurol Sci.
1999;
170
77-89
-
6
Kwan S Y, Lin J H, Su M S.
Co-existence of epilepsy, myasthenia gravis and psoriasis vulgaris.
Chin Med J.
2000;
63
153-157
-
7
Lindstrom J.
Nicotinic acetylcholine receptors in health and disease.
Mol Neur.
1997;
15
193-222
-
8
Ronziere T, Auzou P, Ozsancak C, Magnier P, Senant J, Hannequin D.
Myasthenic syndrome induced by lithium.
Presse Med.
2000;
29
1043-1044
Dr. Mary D. King
Department of Paediatric Neurology, The Children's University Hospital
Temple Street
Dublin
Ireland
Email: mary.king@tsch.ie
